Tailoring Antibodies to Suit Emerging Diseases with Ichor Biologics

We explore how Ichor Biologics is leveraging its next-generation platform to harness and improve on antibody-based therapeutics.

We explore how Ichor Biologics is leveraging its next-generation platform to harness and improve on antibody-based therapeutics.